These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6423163)

  • 21. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG; Nielsen LP
    Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-aluminium concentration in dialysis encephalopathy.
    McDermott JR; Smith AI; Ward MK; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8070):901-4. PubMed ID: 76845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aluminium studies in dialysis encephalopathy.
    Elliott HL; Macdougall AI
    Proc Eur Dial Transplant Assoc; 1978; 15():157-63. PubMed ID: 740662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].
    Cartier F; Allain P; Gary J; Chatel M; Menault F; Pecker S
    Nouv Presse Med; 1978 Jan; 7(2):97-102. PubMed ID: 652514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiography of healing dialysis osteodystrophy.
    Barmeir E; Dubowitz B; Hudson GA; Milne FJ; Meyers AM
    Acta Radiol Diagn (Stockh); 1984; 25(2):107-12. PubMed ID: 6375266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
    Charhon SA; Chavassieux PM; Meunier PJ; Accominotti M
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1613-4. PubMed ID: 3924189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D; Simícková J; Kubátko J; Syrovátka P
    Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA; McParland C; Keogh JA
    Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of aluminium in serum, dialysate fluid and water by inductively coupled plasma optical emission spectrometry.
    Lyon TD; Cunningham C; Halls DJ; Gibbons J; Keating A; Fell GS
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():160-6. PubMed ID: 7785943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
    Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of aluminium in patients with acute renal failure.
    Davenport A; Roberts NB
    Nephron; 1989; 52(3):253-8. PubMed ID: 2739864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum aluminium measurement by DC plasma emission spectrometry.
    Roberts NB; Williams P
    Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():169-75. PubMed ID: 3382147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aluminium toxicity in chronic renal insufficiency.
    Savory J; Bertholf RL; Wills MR
    Clin Endocrinol Metab; 1985 Aug; 14(3):681-702. PubMed ID: 3905084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
    Fernández E; Amoedo ML; Montoliu J
    Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aluminium in chronic renal replacement therapy patients undergoing haemodialysis in two renal units in Bogotá].
    Cárdenas O; Segura O; Puentes W; Sanabria M; Nava G; Torrenegra R
    Rev Salud Publica (Bogota); 2010 Aug; 12(4):669-81. PubMed ID: 21340131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for the routine determination of aluminium in serum and water by flameless atomic absorption spectrometry.
    Parkinson IS; Ward MK; Kerr DN
    Clin Chim Acta; 1982 Oct; 125(2):125-33. PubMed ID: 7139954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some aspects related to the presence of aluminium in waters.
    Giordano R; Costantini S
    Ann Ist Super Sanita; 1993; 29(2):305-11. PubMed ID: 8279721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
    Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
    McClure J; Fazzalari NL; Fassett RG; Pugsley PG
    J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.